Severe coronavirus disease 2019 (COVID‐19) pneumonia patients treated successfully with a combination of lopinavir/ritonavir plus favipiravir: Case series

by Hayato Koba, Taro Yoneda, Tomoya Kaneda, Tsukasa Ueda, Hideharu Kimura, Kazuo Kasahara
Published 2020-12-01

Potential mechanisms of nafamostat therapy for severe COVID-19 pneumonia with disseminated intravascular coagulation

by Wakana Takahashi, Taro Yoneda, Hayato Koba, Tsukasa Ueda, Noriaki Tsuji, Haruhiko Ogawa, Hidesaku Asakura
Published 2021-01-01

A case of EGFR mutation-positive lung adenocarcinoma in which the T790M allele fraction was increased by repeated EGFR-TKI treatment

by Hideharu Kimura, Yoshiaki Amino, Hayato Koba, Yuichi Tambo, Noriyuki Ohkura, Johsuke Hara, Takashi Sone, Kazuo Kasahara
Published 2019-11-01

Case report: Migraine that persisted for over 20 years disappears after treatment for pulmonary arteriovenous fistula

by Kazuyuki Kakeshita, Taro Yoneda, Hayato Koba, Kota Tanimura, Tsukasa Ueda, Tomoya Kaneda, Johsuke Hara, Kazuo Kasahara
Published 2020-10-01

Prolonged response to atezolizumab with bevacizumab plus chemotherapy in a patient with lung cancer harboring mutation in EGFR after Afatinib treatment: A case report

by Hayato Koba, Taro Yoneda, Hiroko Morita, Tsukasa Ueda, Ryo Hara, Nanao Terada, Mako Miyakawa, Hideharu Kimura, Kazuo Kasahara
Published 2021-12-01

Molecular features of tumor-derived genetic alterations in circulating cell-free DNA in virtue of autopsy analysis

by Hayato Koba, Hideharu Kimura, Taro Yoneda, Takashi Sone, Noriyuki Ohkura, Johsuke Hara, Kazuyoshi Hosomichi, Atsushi Tajima, Kazuo Kasahara
Published 2021-04-01

Long-lasting responses after discontinuation of nivolumab treatment for reasons other than tumor progression in patients with previously treated, advanced non-small cell lung cance...

by Hideharu Kimura, Tomoyuki Araya, Taro Yoneda, Hiroki Shirasaki, Koji Kurokawa, Tamami Sakai, Hayato Koba, Yuichi Tambo, Shingo Nishikawa, Takashi Sone, Kazuo Kasahara
Published 2019-11-01